Objective: Although experimental work has provided evidence that the thalamus is a crucial relay structure in temporal lobe epilepsy (TLE), the relation of the thalamus to neocortical pathology remains unclear. To assess thalamocortical network pathology in TLE, we mapped pointwise patterns of thalamic atrophy and statistically related them to neocortical thinning.
In temporal lobe epilepsy (TLE), previous studies have suggested that medial thalamic nuclei are involved in the limbic seizure circuitry, 1,2 particularly in relation to spread. 3 Indeed, several medial thalamic subdivisions, such as the mediodorsal nucleus, have dense reciprocal connections with mesiotemporal 4 and neocortical cortices. 5, 6 In addition, animal data provide histopathologic evidence for cell loss in medial subdivisions that coupled with synaptic alterations can enhance the excitability of thalamic seizure circuits. 7, 8 A seminal postmortem study described thalamic cell loss and gliosis in a high proportion of patients. 9 Consistent with these observations, MRI volumetric analysis has demonstrated decreased global thalamic volume in TLE. 10 Neither of these studies specified the localization of changes with respect to nuclear divisions. Although the topographic distribution of atrophy in temporolimbic and frontocentral cortices observed in MRI studies of TLE is suggestive of seizure-related damage via thalamocortical spread, the relation between thalamic and neocortical pathology remains unclear. Recently developed MRI processing techniques based on spherical harmonic shape descriptions (SPHARM) allow localizing atrophy through the evaluation of inward displacements across thousands of points on the surface of a given structure. 11 These techniques capture the most salient shape characteristics while guaranteeing anatomic correspondence across subjects, a requirement for sensitive and reliable statistics.
To assess thalamocortical network pathology in drug-resistant TLE, we first mapped pointwise patterns of thalamic atrophy. We then statistically related local thalamic atrophy to neocortical thinning. METHODS Subjects. We studied 36 consecutive patients referred to our hospital for the investigation of drug-resistant TLE. Demographic and clinical data were obtained through interviews with patients and their relatives. Diagnosis and lateralization of the seizure focus into left TLE (LTLE) (n ϭ 18) and right TLE (RTLE) (n ϭ 18) were determined by a comprehensive evaluation including detailed history, video-EEG telemetry, and neuroimaging. None of the patients had a mass lesion (malformation of cortical development, tumor, or vascular malformation) or traumatic brain injury. Based on manual hippocampal volumetry, 12 24 patients had unilateral hippocampal atrophy ipsilateral to the focus and 12 had normal hippocampal volume.
Twenty-nine patients underwent operations. We determined surgical outcome according to the Engel classification scheme 13 at a mean follow-up time of 5.3 Ϯ 3.4 years. Twenty (69%) patients had an outcome of class I, 4 (14%) of class II, 4 (14%) of class III, and 1 (3%) of class IV. After qualitative histopathologic analysis, hippocampal sclerosis was detected in all 20 patients in whom hippocampal specimens were available. In the remaining 9, specimens were unsuitable for histopathology because of subpial aspiration. The control group consisted of 19 age-and sex-matched healthy individuals. Detailed information on patients and control subjects is presented in the table.
Standard protocol approvals, registrations, and patient consents. The Ethics Committee of the Montreal Neurological
Institute and Hospital approved the study, and written informed consent was obtained from all participants.
MRI acquisition.
Magnetic resonance images were acquired on a 1.5-T Gyroscan (Philips Medical Systems, Eindhoven, The Netherlands) using a 3-dimensional T1 fast-field echo sequence (repetition time ϭ 18 msec; echo time ϭ 10 msec; number of excitations ϭ 1; flip angle ϭ 30°; matrix size ϭ 256 ϫ 256; field of view ϭ 256 ϫ 256 mm 2 ; slice thickness ϭ 1 mm), providing isotropic voxels of 1 ϫ 1 ϫ 1 mm.
Cortical thickness measurements.
As in our previous work, 14, 15 we applied the constrained Laplacian anatomic segmentation using proximity algorithm 16 to automatically generate a model of the cortical surface and to measure cortical thickness across 81,924 surface-spanning points (henceforth vertices). In brief, images underwent automated correction for intensity nonuniformity and intensity standardization and were linearly registered into a standardized stereotaxic space based on the Talairach atlas. Images were automatically classified into gray matter (GM), white matter (WM), and CSF. A surface mesh was then iteratively warped to fit the boundary between WM and GM in the classified image. The WM/GM boundary was expanded a second time along a Laplacian map to generate an outer surface that runs along the GM/CSF boundary. Extracted surfaces were nonlinearly aligned using a 2-dimensional registration procedure that improves the anatomic correspondence of vertices in all subjects. Thickness data were blurred using a surface-based diffusion-smoothing kernel of 20-mm full-width at halfmaximum that preserves cortical topology.
Surface-based mapping of the thalamus. We manually segmented the left and right thalamus in healthy control subjects and patients according to our previously published protocol. 10 Each thalamic label was binarized and underwent a minimal smoothing operation before being converted to surface meshes for which a parameterization using spherical harmonics (SPHARM) was computed using an area-preserving, distortionminimizing mapping. 11 Based on a uniform icosahedron subdivision of the parameterization, we then obtained a point distribution model (PDM), allowing shape-inherent point correspondences across subjects. Thalamic SPHARM-PDM surfaces of each individual (control subjects and patients) were rigidly aligned to a template constructed from the mean surface of control subjects and patients with respect to the centroid and the longitudinal axis of the first-order ellipsoid. For each thalamic hemisphere, we then calculated displacement vectors between each subject and the template across 1,002 vertices. The inward displacements of the signed surface-normal components of these vectors allowed mapping thalamic atrophy. Figure 1 illustrates the SPHARM-PDM processing steps.
Statistical analysis.
We conducted the analyses using SurfStat (http://www.math.mcgill.ca/keith/surfstat/) toolbox for Matlab (R2007a; The MathWorks, Natick, MA).
Thalamic mapping. We mapped thalamic atrophy in TLE relative to that in control subjects using vertex-wise one-tailed t tests. In clusters (i.e., regions of contiguous vertices) of significant atrophy, mean displacement measurements were normalized through a z transformation relative to the distribution of control subjects to determine the proportion of individuals with atrophy.
Thalamocortical correlation analysis. We mapped cortical thinning in patients with TLE relative to that in control subjects using vertex-wise one-tailed t tests. After extracting the mean displacement in regions of thalamic atrophy (obtained in the previous section), we correlated this value both with the mean thickness in clusters of significant neocortical thinning and with cortical thickness at each vertex in patients. These 2 complementary correlation analyses allowed both a post hoc investigation and an unbiased exploration of the statistical relationship between thalamic atrophy and neocortical thinning. Using linear interaction models, we also assessed differences in thalamocortical correlations between patients with TLE and control subjects. Clinical analysis. In clusters of thalamic atrophy, we assessed the effects of disease duration, febrile convulsions, and seizure frequency estimates on thalamic volume using linear models. Because seizure frequency followed a highly skewed distribution, we used its logarithm. To assess the utility of surfacebased thalamic shape analysis data to lateralize the seizure focus, we first determined asymmetries using paired t tests between corresponding vertices in the ipsilateral and contralateral thalamus. We then fed into a linear discriminant classifier mean thalamic displacement vectors in clusters of significant asymmetry. Cross-validation of the classification was performed using a leave-one-out approach. This procedure, by which an individual patient is lateralized using only the data of all other subjects, allows an unbiased assessment of lateralization performance for previously unseen cases of TLE.
Correction for multiple comparisons. We corrected significances using random field theory for nonisotropic images on a cluster level, 17 thereby controlling the chance of ever reporting a false-positive finding to be below a family-wise error of 0.05. To illustrate trends, significances were also displayed at an uncorrected threshold of p Ͻ 0.03.
Localization of findings. We schematically outlined the main thalamic subdivisions (anterior, ventral/lateral, medial, and posterior) on the surface template according to the histologic parcellation described by Morel et al. 18 RESULTS Mapping thalamic atrophy. LTLE and RTLE displayed a similar pattern of ipsilateral atrophy ( p Ͻ 0.05) ( figure 2, A and B) . The region of atrophy common to both groups (defined as the overlap at p Ͻ 0.05) was located along the ipsilateral medial thalamic surface and encompassed anterior, medial, and posterior divisions ( figure 2C ). In these areas, elevated proportions of patients with TLE, but not control subjects, had abnormally low z scores (at Ϫ1.5 threshold: LTLE 56% [ ally, only small trends were seen in anterior and posterior divisions ( p Ͻ 0.03, uncorrected). Despite a tendency for patients with LTLE to be slightly older than healthy control subjects ( p ϭ 0.09), after the analysis was repeated with age as a nuisance parameter, results remained unchanged.
Relationship of thalamic atrophy to neocortical thinning. Group analysis of cortical thickness comparing patients with control subjects showed marked cortical thinning in multiple areas encompassing bilateral frontocentral, lateral temporal, and parietal, as well as ipsilateral mesiotemporal and temporo-occipital cortices ( figure 3A) . In each TLE group, post hoc analysis revealed a positive correlation between the mean displacement in ipsilateral medial thalamic atrophy common to both TLE groups (as shown in figure 2C ) and mean thickness in clusters of frontal and mesiotemporal atrophy (t Ͼ 2.1, p Ͻ 0.03) (figure 3B). Interaction analysis revealed that these correlations were significantly higher in patients than in control subjects (t Ͼ 1.92, p Ͻ 0.04), indicating a clear association between cortical thinning and ipsilateral medial thalamic atrophy in TLE. In a separate unbiased analysis, the correlation between the mean displacement in regions of thalamic atrophy common to both TLE groups ( figure 2C ) and thickness of each cortical vertex mapped bilateral frontocentral, parietal, lateral temporal and mesiotemporal cortices ( figure 3C ) in a distribution that resembled patterns of groupwise neocortical thinning shown in figure 3A . Findings were similar in patients with LTLE and RTLE.
Clinical analysis. In TLE, a longer duration of epilepsy was associated with more marked medial thalamic atrophy (Ϫ0.02 mm/year, t ϭ 2.63, p Ͻ 0.01) (figure 4A), whereas there was no main effect of age in this cluster in control subjects (t ϭ 1.3, p Ͼ 0.1). There was a trend for more severe atrophy in patients with a history of febrile convulsions compared with those without (t ϭ 1.66, p Ͻ 0.06) ( figure 4B ). In contrast, medial thalamic atrophy was not related to postsurgical outcome (Engel I vs II-IV: t ϭ Ϫ0.60, p Ͼ 0.25) or log seizure frequency (t ϭ 0.9, p Ͼ 0.3). Linear discriminant analysis of thalamic asymmetry correctly lateralized 81% (29 of 36) of patients with TLE. If we consider only patients with normal hippocampal volume (n ϭ 12), all were correctly lateralized. DISCUSSION Using 3-dimensional surface modeling of high-resolution MRI, we statistically mapped thalamic atrophy, located mainly in the ipsilateral medial divisions. Patterns were consistent in patients with LTLE and RTLE, intensified with a longer duration of epilepsy, and tended to be more severe in those with a history of febrile convulsions. Thalamic atrophy positively correlated to cortical thinning in bilateral frontal and ipsilateral mesiotemporal regions.
Previous imaging studies have applied voxel-based morphometry to localize structural thalamic abnormalities in TLE. 19 -22 This approach allows statistical inference at the resolution of individual voxels, resulting in increased anatomic precision compared with volumetry. 10 However, inferences in voxelbased morphometry are based on smoothed images in a standard space, an approach that may be biased by registration errors. 23 Although isotropic smoothing partly overcomes these problems, it may amplify undesirable partial volume effects, thereby reducing the detection of focal abnormalities, especially at the boundary of the structure. These limitations may have contributed to the divergence between studies in terms of extent and location of thalamic atrophy. Indeed, some showed bilateral diffuse changes, 19, 24 whereas others reported variable patterns of unilateral atrophy. 21, 22 In this study, instead of a voxel-based segmentation of thalamic nuclei, we adopted a surface-based analysis framework. Although this approach may not assess optimally structural changes in deep thalamic divisions, it provides a means to evaluate structural changes along the thalamic surface manifold at a submillimetric scale and therefore circumvents limitations imposed by the voxel resolution of the MRI. Moreover, by guaranteeing intersubject shape correspondence, the spherical harmonic framework allowed mapping shape deformations onto a study-specific template surface. On this template surface we schematically outlined thalamic subdivisions according to histologic parcellation. In contrast to voxel-based morphometry, the shape-driven registration method in SPHARM brings the vertex locations, but not the dependent variables (i.e., the displacements along the surface normal direction between a given thalamus and a template) into correspondence. Conceptually, this approach resembles the cortical thickness surface registration (albeit higher order), in which the locations of surface vertices are aligned across subjects in terms of cortical anatomy.
The spatial distribution of thalamic atrophy in our patients is in close agreement with histopathologic data from animal models of TLE showing cell loss mainly in medial thalamic divisions. 7, 8 In addition, there is evidence from electrophysiologic data for increased neuronal excitability in the same nuclei, 7 probably playing a crucial role in the generation figure 2C ). (C) Correlation analysis between medial thalamic atrophy (as defined in figure 2C ) and cortical thickness at each vertex. Significances are thresholded using random field theory for nonisotropic images (black outlines, p Ͻ 0.05).
and spread of limbic seizures to the neocortex. 25 These synaptic alterations may not only result from cell loss but also from abnormal structural plasticity at the level of single cells. Indeed, a recent study in pilocarpine-induced status epilepticus showed marked long-term increases in T-type calcium channels in the midline region, 26 further supporting a role for altered distribution of receptor channels in thalamic hyperexcitability. Thalamic abnormalities in our patients extended to posterior divisions corresponding to the location of the medial pulvinar. The involvement of this thalamic division in seizures of temporal lobe origin has been corroborated by MRI studies showing perfusion and diffusion changes after complex partial status epilepticus 27 and intracerebral EEG recordings. 28 Thalamic abnormalities have also been reported in several PET studies. 29, 30 Ipsilateral thalamic glu-cose hypometabolism and decreased binding to flumazenil, a benzodiazepine antagonist mapping ␥-aminobutyric acid A receptors, have been observed in mediodorsal thalamic divisions and were shown to directly correlate with the degree of thalamic atrophy. 30 The wide availability and noninvasive nature of MRI postprocessing quantifying fine-grained anatomic changes, combined with metabolic and functional imaging, will undoubtedly further our understanding of pathologic interactions in future studies of TLE.
We assessed thalamocortical networks by correlating thalamic changes with thickness of the entire neocortex. This unbiased analysis revealed a significant statistical association between ipsilateral medial thalamic atrophy and cortical thinning in bilateral frontal, temporal neocortical, and mesiotemporal regions. Indeed, these thalamic nuclei have been shown to project to the neocortex in a bilateral fashion. 31 Interestingly, the spatial distribution of the patterns observed through correlational analysis closely overlapped with regions of neocortical atrophy obtained when TLE patients were compared with control subjects in this and other cohorts. 32, 33 Although we cannot infer true causality, given our cross-sectional study design, our results suggest that the degree and distribution of thalamic pathology relates to the topography and extent of neocortical thinning in TLE. Furthermore, our morphometric findings complement those obtained from electrophysiology regarding a pivotal role of thalamic midline regions in the spread of limbic seizures in patients with TLE. 2, 28 Nonlinear correlation analysis of EEG signals demonstrated that thalamic activity is consistently coupled with epileptic discharges in temporal lobe regions. 2 Furthermore, studies of cerebral blood flow dynamics using single PET have shown that, although the early phase of complex partial seizures does not involve the thalamus, 34 at late stages (probably reflective of seizure spread), hyperperfusion involves both temporal and mediodorsal thalamic regions, with simultaneous hypoperfusion in frontal and parietal regions. 35 A recent study did not find any noteworthy correlations between thalamic atrophy and neocortical thinning, 36 and the role of the thalamus in the occurrence of extratemporal pathology in TLE was questioned. A number of methodologic differences may have contributed to the divergence between this study and our work. With respect to patient selection, none of our subjects had epilepsy related to head trauma, because posttraumatic epilepsy may present with different clinicopathologic features 37 and structural changes due to the trauma itself. 38
Figure 4
Clinical correlations Effects of duration of epilepsy (A) and history of febrile convulsions (B) on medial thalamic atrophy (as defined in figure 2C ).
Moreover, instead of assessing the relationship between global thalamic volume and cortical thickness, we purposely correlated areas of the thalamus that displayed groupwise atrophy with regions of neocortical thinning, an approach that may have resulted in a higher specificity to map pathologic networks. Further emphasis on the role of the thalamus as an important hub in the pathologic network of TLE stems from similar vulnerability of this structure and the hippocampus with respect to febrile seizures and disease duration. 39 In addition, we were able to lateralize the seizure focus in the vast majority of our patients solely on the basis of mapping thalamic atrophy. Although sample sizes were modest, automatic lateralization performance using linear discriminant function analysis was highly accurate in the subgroup of patients with normal hippocampal volumetry. These findings suggest potential diagnostic benefits in the presurgical assessment of TLE through the use of advanced morphometric analysis of extratemporal limbic regions. By localizing structural abnormalities more precisely, these techniques may also improve the identification of potential targets for deep brain stimulation in drug-resistant epilepsy. 40
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